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Mitochondria are multifaceted and indispensable organelles
required for cell performance. Accordingly, dysfunction to
mitochondria can result in cellular decline and possibly the
onset of disease. Cells use a variety of means to recover mito-
chondria and restore homeostasis, including the activation of
retrograde pathways such as the mitochondrial unfolded pro-
tein response (UPRmt). In this Minireview, we will discuss how
cells adapt to mitochondrial stress through UPRmt regulation.
Furthermore, we will explore the current repertoire of biologi-
cal functions that are associated with this essential stress-re-
sponse pathway.
Mitochondria are double membrane organelles commonly
associated with the production of cellular energy via oxidative
phosphorylation (OXPHOS).2 Mitochondria are also required
for the metabolism of nucleotides, amino acids, and lipids and
have an essential function in regulating apoptosis. Maintaining
mitochondrial integrity is therefore a key aspect in ensuring
cellular and organismal viability. Consequently, a decline in
mitochondrial function is frequently associated with the devel-
opment of numerous diseases (1).
Mitochondria are dependent on a diverse compilation of
proteins to carry out their vital functions. However, the mito-
chondrial proteome is faced with various challenges, most
notably the partitioning of protein encoding genes between the
mitochondrial and nuclear genomes. Remarkably, the human
mitochondrial genome only encodes 1% of the total mito-
chondrial proteomewith the remaining proteins being encoded
by nuclear genes (2). Sophisticatedmechanisms have evolved to
efficiently transfer nuclear-encoded mitochondrial proteins to
their proper organelle destination following translation on
cytosolic ribosomes. To accomplish this complex task, proteins
are sorted to mitochondria via targeting sequences that form
characteristic amphipathic helices composed of positively
charged residues. Such mitochondrial targeting sequences
(MTS) are recognized and translocated via the mitochondrial
Tom–Tim complex to their respective sub-organelle compart-
ment (3). Exquisite coordination of expression between the
mitochondrial and nuclear genomes exists during mitochon-
drial biogenesis, as failure in genome coordination can disrupt
the precise stoichiometry of these OXPHOS complexes result-
ing in orphan subunit accumulation and proteotoxicity (4).
Further contributing to mitochondrial proteotoxicity is the
possible damage to the mitochondrial genome from reactive
oxygen species (ROS) produced byOXPHOSmachinery as well
as the ill effects of various environmental toxins. Mechanisms
must therefore exist to ensure the protection of the mitochon-
drial proteome.
Quality control of the mitochondrial proteome includes the
functions of mitochondrial chaperones that assist in proper
protein folding and proteases that promote clearance of mis-
folded proteins (5). Each sub-compartment of mitochondria
houses its own quality control machinery to ensure protein
homeostasis and organelle function. One way this is achieved is
through retrograde signaling whereby stressed mitochondria
signal to the nucleus to transcriptionally regulate a set of genes
that assist in restoring mitochondrial activity. This Minireview
will discuss the regulation and function ofmitochondrial retro-
grade signalingwith a focus on themitochondrial unfoldedpro-
tein response (UPRmt).
Mitochondrial UPR regulation
Caenorhabditis elegans
The UPRmt is a mitochondrial stress signaling pathway dis-
covered in mammalian cells (6), but much of what is known
with regard to its regulation was discovered in C. elegans (Fig.
1A). Conditions that increase mitochondrial proteotoxicity
such asmitochondrial DNAdepletion, impairedmitochondrial
protein quality control machinery, and OXPHOS perturbation
elicit theUPRmt (7, 8). A number ofUPRmt regulators have been
discovered using genetic approaches, including the mitochon-
drial matrix protease ClpP, the ubiquitin-like protein UBL-5,
the transcription factor DVE-1, the mitochondrial ABC trans-
porter HAF-1, and the bZIP transcription factor ATFS-1 (9,
10). The current paradigm suggests that ClpP proteolytically
degrades improperly foldedmitochondrial proteins with a sub-
sequent release of the resulting peptides frommitochondria via
HAF-1 leading to UPRmt activation (9, 10). Howmitochondrial
peptide extrusion affects the activity of the UPRmt is unclear,
but it is clear that HAF-1 is not essential for UPRmt activation
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and instead serves as a modulator that impacts the nuclear
accumulation of the bZIP transcription factor ATFS-1, a piv-
otal regulator of the UPRmt (7, 10).
ATFS-1 harbors two sorting signals able to target it to both
mitochondria and the nucleus (7, 11). Under physiological con-
ditions, the MTS directs the localization of ATFS-1 to mito-
chondriawhere it is degraded by the protease Lon (7).However,
mitochondrial import efficiency is reduced during conditions
that perturb mitochondrial function (7, 12–14), causing
ATFS-1 to accumulate in the cytosol and subsequently be
imported into the nucleus via its nuclear localization sequence.
ATFS-1 regulates a diverse transcriptional response to recover
mitochondrial function, including the induction of mito-
chondrial proteases and chaperones, xenobiotic and ROS-
detoxifying genes, and metabolic regulators (7). The concept
of mitochondrial import efficiency regulating the UPRmt is
reminiscent of Pink1 kinase regulation in the detection and
removal of defective mitochondria by mitophagy (15). During
mitophagy, damaged mitochondria are marked for removal by
Pink1 leading to recruitment of the autophagic machinery (15).
Pink1 is imported into unstressed mitochondria and degraded
(16). However, mitochondrial dysfunction reduces the import
efficiency of Pink1 allowing it to accumulate on the outer mito-
chondrial membrane where it initiates a cascade leading to
mitochondrial clearance (17). Thus mitochondrial import effi-
ciency may be used as a general indicator of perturbed mito-
chondrial function to activate mitochondrial recovery pro-
grams such as the UPRmt and mitophagy.
Additional regulators of the UPRmt have been identified that
potentially shed light into the inputs of this protective program.
Using a genetic approach, two metabolic pathways were iden-
tified as important regulators of the UPRmt (18). First, knock-
down of components in the sphingolipid biosynthesis pathway,
including the enzymes serine palmitoyltransferase and cer-
amide synthase, results in UPRmt attenuation that can be res-
cued with ceramide supplementation. Interestingly, ceramide
was found to accumulate at mitochondria prior to UPRmt acti-
vation (18). Also, inhibition of the sphingolipid biosynthesis
pathway could not blockUPRmt activation from a gain-of-func-
tion ATFS-1 that is constitutively nuclear irrespective of mito-
chondrial stress (18, 19). Therefore, ceramide accumulation at
mitochondria may be an early step in the activation of the
UPRmt. In the same genetic screen, knockdown of 3-hydroxy-
3-methylglutaryl-CoA (HMG-CoA) synthase, a component of
the mevalonate pathway, also blocked UPRmt activation in the
presence ofmitochondrial stress (18). Themevalonate pathway
is necessary for the synthesis of isoprenoids such as cholesterol.
Interestingly, constitutive nuclear accumulation ofATFS-1 res-
cues the ill effects of statins, a class of cholesterol-lowering
drugs that inhibit the mevalonate pathway (19) likely by
increasing ubiquinone biosynthesis that is impaired by the
statins. Intriguingly, statins block UPRmt activation during
mitochondrial stress suggesting that the side effects experi-
enced while taking this drug may be due to an inability to sense
and respond to conditions that perturbmitochondrial function
(18). In addition to the synthesis of cholesterol, the mevalonate
pathway is also important for the production of prenylated lip-
ids such as farnesyl pyrophosphate that can be blocked with
statin treatment (20). Protein prenylation involves the addition
of the farnesyl moiety to client proteins (21), a reaction that is
particularly crucial for the activity of small GTPases (22).
Importantly, gain-of-function ATFS-1 animals are also resist-
ant to the toxicity exerted by gliotoxin (19), which blocks the
addition of farnesyl to small GTPases through the inhibition of
farnesyl transferase. This suggests that impaired prenylation
may contribute to the negative effects of statins. Perhaps
GTPase prenylation is required for UPRmt activation that can
bemitigated through constitutive activation of ATFS-1. In sup-
port of this possibility, the small GTPase Rheb is required for
UPRmt activity (9).
Recent observations suggest that chromatin remodeling is
also critically required for UPRmt activity. In the first study, the
histone lysine demethylases JMJD-1.2 and JMJD-3.1 were dis-
covered in a genetic screen for positive UPRmt regulators (23).
Both show specificity for histone H3K27me2/me3 and are
required and sufficient for the UPRmt. Consistent with mediat-
ing a mitochondrial protective transcriptional response, genes
differentially expressed from JMJD-1.2 and JMJD-3.1 overex-
pression show significant overlap with gene expression profiles
of mitochondrially stressed animals with perturbed OXPHOS
(23). Analogous findings were also observed with the mamma-
lian homologs of JMJD-1.2 (Phf8) and JMJD-3.1 (Jmjd3), sug-
gesting a conservedmechanismofUPRmt regulation (23). In the
second study, the H3K9 methyltransferase MET-2 and the
novel protein LIN-65 were found to positively regulate
the UPRmt (24). LIN-65 is initially cytosolic but localizes to
the nucleus in the presence of mitochondrial stress in a MET-
2-dependent manner (24), suggesting they are functionally
Figure 1. Regulation of the UPRmt in C. elegans and mammals. A, in
C. elegans, the UPRmt is principally regulated by the bZIP transcription factor
ATFS-1 that contains both mitochondrial and nuclear sorting sequences. In
the absence of mitochondrial stress, ATFS-1 localizes to mitochondria and is
degraded by the protease Lon. Perturbation to mitochondrial function
reduces mitochondrial import efficiency causing an accumulation of cytoso-
lic ATFS-1 and subsequent nuclear import. ATFS-1 regulates a diverse tran-
scriptional program to recover mitochondrial function, including the attenu-
ation of OXPHOS gene expression in both the nucleus and mitochondria.
Multiple regulators of theUPRmt have been identified, including the protease
ClpP and the ABC transporter HAF-1 that control UPRmt activity through an
unidentifiedmechanism involvingpeptideefflux.B,mammalianUPRmt is reg-
ulated by the transcription factors CHOP and ATF5 that transcriptionally reg-
ulate genes to restore mitochondrial homeostasis. CHOP is transcriptionally
activatedby transcription factor c-Junduringmitochondrial stress. ATF5 con-
tainsmitochondrial and nuclear localization sequences similar to ATFS-1 that
regulate UPRmt activity based on the efficiency of mitochondrial import.
MINIREVIEW: Mitochondrial recovery via the UPRmt
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related. Indeed, both MET-2 and LIN-65 are required for the
methylation of histoneH3K9 that is needed for accumulation of
the UPRmt transcriptional regulator DVE-1 into discrete
nuclear puncta, specifically to chromatin regions thought to
represent sites of active gene expression (9, 24). These findings
add an extra layer of complexity to the regulation of the UPRmt,
suggesting that epigenetic modifications are a necessary step
for the activation of this mitochondrial recovery program.
Remarkably,mitochondrial damage originating fromone tis-
sue can induce a UPRmt in distal tissues via cell non-autono-
mous signaling (Fig. 2) (25). For example, neuronal mitochon-
drial dysfunction can induce theUPRmt in the intestine through
the production of secreted “mitokines” (25). Presumably, sen-
sory neurons that are in contact with the external environment
housing potentially damaging toxins would be ideal to relay
mitochondrial stress signals to tissues, like the intestine, that
are likely to be impacted by toxin exposure during feeding. Two
recent advancements have been made into the identity of the
mitokines that regulate the cell non-autonomous control of the
UPRmt. In the first study, the bioamine neurotransmitter sero-
tonin was found to be required for activation of the UPRmt in
the intestine as a consequence of mitochondrial protein aggre-
gate accumulation in neurons (26). In a parallel study, interneu-
ron secretion of the neuropeptide FLP-2 was necessary and
sufficient for UPRmt activation in the intestine (27). Flp-2 tran-
script levels are enhanced in the presence of neuronal mito-
chondrial stress, consistent with a role in the cell non-autono-
mous regulation of theUPRmt. Indeed, overexpression of FLP-2
specifically activates the UPRmt and not other stress responses
(27). Together, these studies suggest that neuronal control of
theUPRmt in distal tissues is likely complex involving the secre-
tion of multiple mitokine signals. Going forward, it will be
interesting to understand how these various mitokines are reg-
ulated in a coordinated manner in response to varying forms of
mitochondrial dysfunction as well as their role in regulating
whole-animal metabolism.
Mammals
The UPRmt was first discovered inmammalian cultured cells
expressing a misfolded mitochondrial protein that resulted in
increased expression of mitochondrial protein quality control
genes in the nucleus (Fig. 1B) (6). This transcriptional response
to mitochondrial dysfunction is thought to require the C/EBP
transcription factor CHOP as the corresponding consensus
binding site is present inmultiple genes that are induced during
the UPRmt (28, 29). Consistently, CHOP is transcriptionally
induced during theUPRmt presumably by the transcription fac-
tor c-Jun (6, 28).
Inspired by the discovery of ATFS-1, Fiorese et al. (30) iden-
tified the bZIP transcription factor ATF5 as an additional reg-
ulator of the UPRmt response. Mitochondrial import efficiency
appears to regulate ATF5 in a manner akin to ATFS-1 because
ATF5 also contains a presequence that directs its localization to
mitochondria in the absence of mitochondrial stress (30). Sim-
ilar to ATFS-1, ATF5 transcriptionally regulatesmitochondrial
protective gene expression that is necessary for cell growth dur-
ing mitochondrial stress (30). Interestingly, ATF5 can induce a
UPRmt inC. elegans in the absence of ATFS-1 suggesting that it
is a conserved mammalian homolog (30). However, there are
still questions left unanswered with regard to ATF5 and the
mammalian UPRmt. First, is ATF5 proteolytically degraded in
healthy mitochondria by LONP1 similar to ATFS-1? LONP1
expression is transcriptionally induced during the UPRmt by
ATF5 suggesting a functional relationship (30). Second, does
ATF5 accumulation in the nucleus during the UPRmt require
ClpP-derived peptide efflux via the mammalian homolog of
HAF-1 (TAP)? Finally, how are ATF5 and CHOP coordinated
during the UPRmt? Interestingly, the CHOP consensus
sequence is present in some genes that are also regulated by
ATF5 during the UPRmt (28, 30) suggesting some degree of
overlap in target gene regulation. Further work is therefore
needed to better understand the specific mechanisms of ATF5
regulation during the UPRmt.
The mitochondrial intermembrane space (IMS) contains its
own suite of protein quality machinery and potentially distinct
stress response. Perturbation to the IMS protein folding envi-
ronment elicits a protective response through the phosphory-
lation of the estrogen receptor  by Akt (31). In a recent study,
proteotoxicity to the mitochondrial matrix and IMS activated
the deacetylase SirT3 to promote mitochondrial recovery
through the activation of anti-oxidant machinery and the stim-
ulation ofmitophagy (32). Presumably, the SirT3 response dur-
ingmitochondrial stress is mediated by the transcription factor
FOXOA3 that accumulates in the nucleus following SirT3-me-
diated deacetylation (32).
Comparison of the UPRmt and UPRER
Much like mitochondria, the endoplasmic reticulum (ER) is
prone to the accumulation of misfolded proteins and similarly
responds to increases in proteotoxicity through the transcrip-
tional up-regulation of ER chaperones and proteases to restore
protein homeostasis via theUPRER (33). Although conceptually
similar to the UPRmt, the UPRER possesses distinct signaling
mechanisms that are involved in its regulation. There are three
main regulatory pathways that govern the UPRER: the serine/
threonine kinase/endonuclease IRE1; the bZIP transcription
factor ATF6; and the kinase PERK. All three proteins are bound
in an inactive state to the ER chaperone BiP and are released in
Figure 2. Cell non-autonomous regulation of the UPRmt. Mitochondrial
dysfunction in neurons activates the UPRmt in distal tissues such as the intes-
tine through diffusible “mitokine” signals, including the neurotransmitter
serotonin and the neuropeptide FLP-2. stressmt, mitochondrial stress.
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the presence of ER stress. Active IRE1 results in preferential
mRNA splicing of the bZIP transcription factor XBP1 resulting
in its activation and subsequent transcriptional up-regulation
of proteostasis genes. ATF6 also positively regulates the expres-
sion of proteostasis genes following its activation by proteolytic
cleavage.
In addition to transcriptionally regulating the expression of
ER protective genes, the UPRER helps restore ER homeostasis
by attenuating protein translation through PERK-dependent
phosphorylation of the translation initiation factor eIF2 (34).
PERK is among four kinases that constitute the integrated
stress response (ISR) that diminishes protein translation in
response to various cellular stresses (35). Interestingly, the ISR
kinase GCN2 is activated by increased ROS during mitochon-
drial stress and helps restore mitochondrial homeostasis by
lowering cytosolic protein translation via phosphorylation of
eIF2, thus reducing the load of incoming unfolded mitochon-
drial proteins (36). Although general protein translation is
attenuated during the ISR, mRNAs containing upstream open
reading frames (uORFs) are favorably translated. Intriguingly,
ATF5 is among the uORF containing mRNAs that are prefer-
entially translated following eIF2 phosphorylation during ER
stress (37). Whether mitochondrial stress results in a similar
preferential translation of ATF5 is still unknown.
It is noteworthy that the UPRmt andUPRER share some com-
mon regulatory proteins, suggesting a possible intersection in
the regulatory inputs of both stress responses. For example,
CHOP is also activated during ER stress downstream of the
bZIP transcription factor ATF4 (38). In this context CHOP
assumes a pro-apoptotic role by transcriptionally regulating
ATF5, but whether a similar mode of regulation occurs during
UPRmt activation is not known (39). In contrast to the pro-apo-
ptotic role of CHOP and ATF5 during ER stress, these tran-
scription factors adopt a pro-survival function during mito-
chondrial stress through the regulation of mitochondrial
protective gene expression (6, 30). Possibly, CHOP and ATF5
undergo stress-specific post-translationalmodifications or het-
erodimerization that dictate their particular function.
Physiological roles of the UPRmt
Protection against pathogen infection
Mitochondria are desirable targets for bacterial pathogens
during infection. For example, various pathogens manipulate
mitochondrion-dependent cell death pathways to promote
their own survival (40). Mitochondria also play an important
role in regulating the innate immune response (41) that can be
compromised during infection by certain pathogens (42). As
such, bacterial pathogens have evolved variousmeans to exploit
mitochondrial function, including the precise targeting of pro-
tein virulence factors directly to mitochondria (43).
Host resistance to infection is dependent on innate and
adaptive immune responses that limit the colonization of path-
ogenic microbes. In contrast, host tolerance during infection is
defined as the ability to withstand the damage caused by harm-
ful pathogens and possibly the self-damage inflicted by the host
resulting from the inflammatory response (44). The UPRmt
supports host tolerance by regulating mitochondrial recovery
while additionally promoting host resistance through the tran-
scriptional regulation of various innate immunity genes such as
secreted anti-microbial peptides and lysozymes (Fig. 3A) (45).
Various microbes such as the opportunistic pathogen Pseu-
domonas aeruginosa can activate the UPRmt through the pro-
duction of mitochondrial toxins (18, 45). Consistent with a role
in protecting the host from infection, ATFS-1 is required and
sufficient for survival during P. aeruginosa infection (45, 46).
Interestingly, the mitochondrial chaperone HSP-60 that is
transcriptionally up-regulated during the UPRmt by ATFS-1 (7,
10, 11) promotes host resistance during infection by enhancing
the PMK-1/p38 MAPK innate immunity pathway through
direct binding and stabilization of SEK-1/MAPK kinase 3 (46).
The coupling of host tolerance and resistance to one stress-
response pathway is an efficient means of protecting the host
during infection considering that mitochondria are targeted by
a number of pathogens (18, 43, 45). Furthermore, the UPRmt
may be regarded as an additional sensor of infection from the
damage that is inflicted by harmful microbes targeting mito-
chondrial function. It is unclear whether all metazoans couple
the UPRmt to the regulation of innate immunity during infec-
tion. However, the homolog of ATFS-1 in the whiteleg shrimp
induces the expression of antimicrobial peptides and is
required for survival during pathogen infection suggesting that
UPRmt-mediated regulation of host resistance may be con-
served (47).
Accumulation of deleteriousmitochondrial genomes
Deletions inmitochondrial DNA (mtDNA) occur as an orga-
nism ages and contributes to various diseases (48). However,
each cell houses hundreds of mitochondrial genomes as a mix-
ture of wild-type and mutant forms, a phenomenon known as
heteroplasmy (49), and accordingly the number of deleterious
mitochondrial genomes only needs to exceed a certain thresh-
old to be pathogenic (typically comprisingmore than 60%of the
total number of mitochondrial genomes) (49). The mechanism
that regulates the number of deleterious mitochondrial
genomes has remained elusive until the discoveries made by
Figure 3. Biological roles of the UPRmt. The UPRmt supports a variety of
organismal functions, including the regulation of innate immunity during
pathogen infection (A); the control of deleterious mitochondrial genome
numbers (B); mediating metabolic adaptations during mitochondrial stress
(C); and promoting stem cell maintenance (D). stressmt, mitochondrial stress.
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two recent independent studies (50, 51). Here, a C. elegans het-
eroplasmic strain harboring mtDNA with a 3.1-kb deletion
(mtDNA (52)) activated the UPRmt as a result of reduced
OXPHOS activity (50, 51). Surprisingly, loss of the UPRmt
through ATFS-1 inhibition reduced the number of mtDNA
copies, whereas constitutive activation of ATFS-1 promoted
the accumulation ofmtDNA, further reducingOXPHOS effi-
ciency and causing impaired development (50, 51).
How does ATFS-1 promote the accumulation of deleterious
mtDNA? Potentially, the UPRmt limitsmitophagy by promot-
ing mitochondrial health, but ATFS-1 appears to preferentially
promotemtDNAaccumulation independent frommitophagy
(50, 51). ATFS-1 does promote the expression of genes involved
in mitochondrial biogenesis, including regulators of mtDNA
replication such as mtDNA polymerase and TFAM (51) as well
as transcriptionally regulating genes involved in mitochondrial
dynamics (7, 51). Reducing regulators of mtDNA replication
andmitochondrial dynamics attenuate the increasedmtDNA
number that is observed in constitutively active ATFS-1 ani-
mals suggesting that both are involved in the ATFS-1-depen-
dent propagation of mtDNA (51). Together, these studies
reveal an unexpected toxic consequence of the UPRmt mito-
chondrial recovery program that expands mtDNA through
the stimulation of mitochondrial biogenesis (Fig. 3B).
Metabolic adaptations
Paradoxically, in addition to nuclear accumulation, ATFS-1
also accumulates inmitochondria during stress despite reduced
mitochondrial import efficiency (7, 11). Multiple isoforms of
ATFS-1 are present in mitochondria during the UPRmt, but the
exact identity of these isoforms is still unknown. However, two
splice variants of ATFS-1 exist with a difference of just 16
amino acids (11). Although both the short and long ATFS-1
isoforms contain theMTS, it is not knownwhich isoform accu-
mulates in mitochondria during stress. Within mitochondria
ATFS-1 binds the D-loop of mtDNA, an A-T-rich region resid-
ing in the control region adjacent to transcriptional regulatory
elements (11). Here, ATFS-1 limits the abundance of OXPHOS
transcripts encoded by the mitochondrial genome. ATFS-1
regulates mitochondrial OXPHOS transcript numbers poten-
tially through transcriptional repression via its association with
the D-loop region; however, its effects on transcript stability
have yet to be studied. Interestingly, ATFS-1 also negatively
regulates nuclear-encoded OXPHOS gene transcript abun-
dance through direct or indirect binding of their gene promot-
ers (11). Thus, ATFS-1 appears to transcriptionally attenuate or
limit OXPHOS biogenesis until the protein folding capacity is
restored as a means of promoting mitochondrial recovery. In
addition to repressing the abundance of OXPHOS transcripts,
ATFS-1 also transcriptionally induces the expression of genes
involved in glycolysis (7, 11). By positively regulating glycolysis
gene expression, ATFS-1 presumably ensures adequate ATP
levels in lieu of reduced OXPHOS activity in an effort to pro-
mote mitochondrial repair and cell survival (Fig. 3C).
Hematopoietic stem cell maintenance
Quiescent stem cells have relatively little mitochondrial
activity that increases during differentiation (53). In the study
by Mohrin et al. (54), the histone deacetylase SIRT7 was found
to reduce mitochondrial translation by complexing with the
central metabolic regulator of mitochondrial gene expression
NRF1 and repressing transcription ofmitochondrial ribosomes
and translation factors. Loss of SIRT7 consequently results in
enhanced mitochondrial translation and biogenesis leading to
the activation of the UPRmt. Interestingly, inhibiting SIRT7 in
hematopoietic stem cells (HSC) enhances mitochondrial bio-
genesis and activates the UPRmt, thus reducing quiescence and
the ability to differentiate. Consistentwith a role inmaintaining
stem cell quiescence, SIRT7 levels are elevated during the qui-
escent stage and low in aged stem cell populations (54). Conse-
quently, increasing SIRT7 levels in aged stem cells decrease
mitochondrial proteotoxicity and improve their differentiation
potential. Although it is still unclear whether specific loss of
UPRmt regulators impacts HSC maintenance, this study sug-
gests the importance of mitochondrial protein homeostasis in
stem cell vitality (Fig. 3D).
The future of the UPRmt
A decline in mitochondrial function likely impacts a wide
range of cellular activities because of the essential nature of the
organelle. Consequently,mitochondrial stress presumably acti-
vates parallel cytoprotective pathways. For instance,mitochon-
drial stress results in the activation of multiple signaling mod-
ules in addition to the UPRmt, including the hypoxia-response
transcription factor HIF-1, the AMP-activated kinase pathway,
and the transcription factors TAF-4 and CEH-23 (55–57). As
well, increased mitochondrial ROS can activate an oxidative
stress response regulated by the transcription factor SKN-1
(58). Intriguingly, ATFS-1 regulates the expression of skn-1 as
part of theUPRmt transcriptional response (9). Finally, accumu-
lation of mitochondrial precursor proteins in the cytosol as a
result of impaired mitochondrial import elicits a separate
stress-response pathway involving reduced protein translation
and increased proteasome activity (12, 14). How the UPRmt
integrateswith these and other cellular stress pathways is there-
fore an area worthy of further investigation.
Also, as the UPRmt is an important regulator of mitochon-
drial recovery, it may be an attractive therapeutic target for
those diseases that result frommitochondrial dysfunction. The
therapeutic potential of the UPRmt is particularly promising in
the field of cancer research. The relationship between mito-
chondrial dysfunction and cancer was first proposed based on
the observation by Otto Warburg that cancer cells utilize gly-
colysis in the presence of oxygen presumably due to a defect in
mitochondrial respiration and function (59). Although this
remains true with certain cancers, it can by no means be
generalized. Indeed, certain cancers display normal or even
enhanced mitochondrial function (60) suggesting a consider-
able heterogeneity in cancer subtypes. It is clear though that
some cancer cells express higher levels of mitochondrial chap-
erones indicative of an activated UPRmt (30, 61–63). The
UPRmt in this context could help support tumor survival from
the mitochondrial dysfunction that may arise from genetic
mutations (64) or through the increase in mitochondrial bio-
genesis used to support tumor growth and proliferation (65).
Interestingly, inhibiting mitochondrial chaperones or the
MINIREVIEW: Mitochondrial recovery via the UPRmt
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UPRmt regulator ATF5 increases tumor cell death while having
little to no effect on healthy cells (30, 63, 66), supporting the
targeting of the UPRmt as an anti-cancer therapy. How the
UPRmt might be pursued for other mitochondrially related
pathologies such as neurological disease and diabetes is still
relatively unexplored and is likely to be an exciting avenue of
research in the field.
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